Latest kidney cancer Stories
SILVER SPRING, Md., Oct. 19 /PRNewswire-USNewswire/ -- The U.S.
PHILADELPHIA, Oct. 5 /PRNewswire/ -- GlaxoSmithKline [NYSE: GSK] today announced that the United States Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) voted unanimously in support of the approval of VOTRIENT(TM) (pazopanib).
FRIMLEY, England, September 25 /PRNewswire/ -- - This Press Release is Intended for Consumer Media Only - Afinitor More Than Doubles the Median Time Without Tumour Growth and Reduces the Risk of Disease Worsening or Death by 67% Compared With Placebo (2) - Patients With Advanced Kidney Cancer Have Limited Options Once Tumours Progress After First Line Standard Therapy(3) - Recently Published UK Expert Clinical Consensus Recommend Afinitor as Second-Line...
WAYNE, N.J. and EMERYVILLE, Calif., May 14 /PRNewswire-FirstCall/ -- Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc.
New treatments are minimally invasive without the side effects of surgery NEW YORK, May 12 /PRNewswire/ -- See video from the Society of Interventional Radiology at: http://inr.mediaseed.tv/SIR_36322/ PROSTATE CANCER A minimally invasive interventional radiology treatment -- focal cryoablation that freezes prostate tumors -- proves as effective as surgery but without the side effects of sexual and urinary dysfunction.
U.S. cancer researchers say they've determined outcomes of robot-assisted kidney cancer surgery are more beneficial to patients than open surgery. Medical scientists at the Fox Chase Cancer Center in Philadelphia led by Dr.
Fighting kidney cancer could be as easy as swapping your next steak for a plate of leafy greens, new research in the Journal of the American Dietetic Association shows.
- Afinitor more than doubled time without tumor growth and reduced the risk of disease progression or death by 67% compared with placebo - Only once-daily oral cancer treatment to directly target mTOR, a protein inside the cell that controls tumor cell division and blood vessel growth - Phase III trials underway to explore potential of Afinitor in multiple additional cancers EAST HANOVER, N.J., March 30 /PRNewswire/ -- Novartis announced today that Afinitor(R) (everolimus) tablets has been...
More Than 75 Percent of Patients Diagnosed Have Small Renal Cell Tumors; Safe Interventional Radiology Treatment Shown Near 100 Percent Effective in Destroying Localized Tumors, Says Johns Hopkins Study SAN DIEGO, March 9 /PRNewswire-USNewswire/ -- Freezing kidney tumors -- using a safe minimally invasive interventional radiology treatment that kills the cancer 100 percent effectively without surgery -- should be the gold standard or first treatment option for all individuals with tumors...
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.